Rastetter William H

Rastetter William H is listed in filings as Director at Neurocrine Biosciences Inc. This profile follows SEC Form 4 activity through May 29, 2026, including sale activity. Recent filings connect the profile to Neurocrine Biosciences Inc (NBIX), FATE THERAPEUTICS INC (FATE), Daré Bioscience, Inc. (DARE), and Regulus Therapeutics Inc. (RGLS). The current snapshot covers public activity from Apr 30, 2025 to May 29, 2026. Reported amounts are shown as $42.3K to $862.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.